[Pegylated interferon-alpha for the treatment of chronic hepatitis C].
作者信息
Weis Nina M, Krarup Henrik Bygum, Skinhøj Peter
机构信息
H:S Hvidovre Hospital, Infektionsmedicinsk Afdeling, DK-2650 Hvidovre.
出版信息
Ugeskr Laeger. 2003 Oct 27;165(44):4211-5.
PMID:14621552
Abstract
摘要
相似文献
1
[Pegylated interferon-alpha for the treatment of chronic hepatitis C].
Ugeskr Laeger. 2003 Oct 27;165(44):4211-5.
2
[Peg-interferon or pegylated interferon].
Rev Infirm. 2003 Jan(87):51-3.
3
[Has hepatitis C become curable by a new pegylated interferon?].
Presse Med. 2001 May 19;30(18):905-8.
4
[Treatment of chronic hepatitis C].
Tidsskr Nor Laegeforen. 2002 Apr 10;122(9):926-8.
5
Interferon alfa, peginterferon alfa and retinopathy.
Prescrire Int. 2006 Apr;15(82):61-2.
6
Ribavirin in chronic hepatitis C: past and future.
Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5.
7
Peginterferon and ribavirin for hepatitis C.
N Engl J Med. 2007 Mar 22;356(12):1269-70; author reply 1271.
8
Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study.
Hepatogastroenterology. 2007 Apr-May;54(75):2 p preceding table of contents.
9
Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
J Drugs Dermatol. 2009 Sep;8(9):870-2.
10
[Treatment of chronic viral hepatitis].
Ugeskr Laeger. 2008 Jun 9;170(24):2137-40.
Zotero 插件